{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:00:47Z","timestamp":1790362847472,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01196-y","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:04:24Z","timestamp":1786428264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of elevated linezolid trough concentrations with hyperlactatemia in elderly patients: a multicenter observational study in China"],"prefix":"10.1186","volume":"27","author":[{"given":"Yaping","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshuai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiao","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"1196_CR1","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2147\/DDDT.S164515","volume":"12","author":"SMR Hashemian","year":"2018","unstructured":"Hashemian SMR, Farhadi T, Ganjparvar M. Linezolid: a review of its properties, function, and use in critical care.[J]. Drug Des Devel Ther. 2018;12:1759\u201367.","journal-title":"Drug Des Devel Ther"},{"key":"1196_CR2","doi-asserted-by":"crossref","unstructured":"Mar\u00eda-Jos\u00e9 et al. Valderrama,Mar\u00eda, Alfaro,Ic\u00edar, Rodr\u00edguez-Avial. Synergy of linezolid with several antimicrobial agents against linezolid-methicillin-resistant staphylococcal strains.[J].Antibiotics (Basel). 2020;9(8):496.","DOI":"10.3390\/antibiotics9080496"},{"issue":"3","key":"1196_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10096-019-03754-1","volume":"39","author":"J Cazavet","year":"2019","unstructured":"Cazavet J, Bounes FV, Ruiz S, et al. Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients.[J]. Eur J Clin Microbiol Infect Dis. 2019;39(3):527\u201338.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"1196_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10096-013-2041-3","volume":"33","author":"HY Dong","year":"2014","unstructured":"Dong HY, Xie J, Chen LH, et al. Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients.[J]. Eur J Clin Microbiol Infect Dis. 2014;33(6):1029\u201335.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"1196_CR5","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.clinthera.2009.10.017","volume":"31","author":"T Niwa","year":"2009","unstructured":"Niwa T, Suzuki A, Sakakibara S, et al. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.[J]. Clin Ther. 2009;31(10):2126\u201333.","journal-title":"Clin Ther"},{"issue":"2","key":"1196_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jinf.2005.04.007","volume":"52","author":"B Von Der Lippe","year":"2006","unstructured":"Von Der Lippe B, Sandven P, Brubakk O. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)\u2014a report of ten cases.[J]. J Infect. 2006;52(2):92\u20136.","journal-title":"J Infect"},{"issue":"8","key":"1196_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1592\/phco.27.8.1189","volume":"27","author":"M Narita","year":"2007","unstructured":"Narita M, Tsuji BT, Yu VL. Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome.[J]. Pharmacotherapy. 2007;27(8):1189\u201397.","journal-title":"Pharmacotherapy"},{"issue":"0","key":"1196_CR8","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/S0163-4453(09)60009-8","volume":"0","author":"DC Vinh","year":"2009","unstructured":"Vinh DC, Rubinstein E. Linezolid: a review of safety and tolerability.[J]. J Infect. 2009;0(0):S59\u201374.","journal-title":"J Infect"},{"issue":"7","key":"1196_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2174\/1389200216666151001121004","volume":"16","author":"K Kishor","year":"2015","unstructured":"Kishor K, Dhasmana N, Kamble SS, et al. Linezolid Induced Adverse Drug Reactions - An Update.[J]. Curr Drug Metab. 2015;16(7):553\u20139.","journal-title":"Curr Drug Metab"},{"issue":"2","key":"1196_CR10","doi-asserted-by":"publisher","first-page":"e259335","DOI":"10.1136\/bcr-2023-259335","volume":"17","author":"V Ramesh","year":"2024","unstructured":"Ramesh V, Gattu S, Maqsood M, et al. Linezolid-induced lactic acidosis.[J]. BMJ Case Rep. 2024;17(2):e259335.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"1196_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.diagmicrobio.2008.08.009","volume":"62","author":"SE Beekmann","year":"2008","unstructured":"Beekmann SE, Gilbert DN, Polgreen PM, et al. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey.[J]. Diagn Microbiol Infect Dis. 2008;62(4):407\u201310.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"1196_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00228-017-2377-1","volume":"74","author":"N Mori","year":"2018","unstructured":"Mori N, Kamimura Y, Kimura Y, et al. Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.[J]. Eur J Clin Pharmacol. 2018;74(4):405\u201311.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"1196_CR13","first-page":"e35891","volume":"15","author":"T Kronen","year":"2023","unstructured":"Kronen T, Agrawal A, Reddy P. Acute Onset Lactic Acidosis Secondary to Linezolid.[J]. Cureus. 2023;15(3):e35891.","journal-title":"Cureus"},{"key":"1196_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijid.2014.12.009","volume":"31","author":"JH Im","year":"2015","unstructured":"Im JH, Baek JH, Kwon HY, et al. Incidence and risk factors of linezolid-induced lactic acidosis.[J]. Int J Infect Dis. 2015;31:47\u201352.","journal-title":"Int J Infect Dis"},{"issue":"0","key":"1196_CR15","doi-asserted-by":"publisher","first-page":"604680","DOI":"10.3389\/fmed.2021.604680","volume":"8","author":"T Liu","year":"2021","unstructured":"Liu T, Hu C, Wu J, et al. Incidence and Associated Risk Factors for Lactic Acidosis Induced by Linezolid Therapy in a Case-Control Study in Patients Older Than 85 Years.[J]. Front Med (Lausanne). 2021;8(0):604680.","journal-title":"Front Med (Lausanne)"},{"key":"1196_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00134-026-08361-1","volume":"52","author":"C Hallie","year":"2026","unstructured":"Hallie C, Prescott, Massimo, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026.[J]. Intensive Care Med. 2026;52:863\u2013936.","journal-title":"Intensive Care Med"},{"issue":"8","key":"1196_CR17","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/jac\/dkae188","volume":"79","author":"T Liu","year":"2024","unstructured":"Liu T, Yuan Y, Wang C, et al. Therapeutic drug monitoring of linezolid and exploring optimal regimens and a toxicity-related nomogram in elderly patients: a multicentre, prospective, non-interventional study.[J]. J Antimicrob Chemother. 2024;79(8):1938\u201350.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"1196_CR18","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1128\/AAC.00177-10","volume":"54","author":"F Pea","year":"2010","unstructured":"Pea F, Furlanut M, Cojutti P, et al. Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.[J]. Antimicrob Agents Chemother. 2010;54(11):4605\u201310.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1196_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/FTD.0b013e3181d5eeee","volume":"32","author":"D Cattaneo","year":"2010","unstructured":"Cattaneo D, Sara B, Francesca C, et al. Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection.[J]. Ther Drug Monit. 2010;32(4):520\u20134.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"1196_CR20","first-page":"s68","volume":"115","author":"H Comite Nacional De","year":"2017","unstructured":"Comite Nacional De H, Oncologia Y, Medicina T, Comite Nacional De N. Iron Deficiency and Iron Deficiency Anemia. Guideline for Prevention, Diagnosis and Treatment.[J]. Arch Argent Pediatr. 2017;115(4):s68\u201382.","journal-title":"Arch Argent Pediatr"},{"issue":"0","key":"1196_CR21","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-208209","volume":"0","author":"AC Davidson","year":"2016","unstructured":"Davidson AC, Banham S, Elliott M, et al. BTS\/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults.[J]. Thorax. 2016;0(0):ii1\u201335.","journal-title":"Thorax"},{"issue":"10","key":"1196_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","volume":"17","author":"EM Boorsma","year":"2020","unstructured":"Boorsma EM, Ter Maaten JM, Damman K, et al. Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment.[J]. Nat Rev Cardiol. 2020;17(10):641\u201355.","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"1196_CR23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.[J]. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1196_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nrneph.2010.20","volume":"6","author":"JC Velez","year":"2010","unstructured":"Velez JC, Janech MG. A case of lactic acidosis induced by linezolid.[J]. Nat Rev Nephrol. 2010;6(4):236\u201342.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1196_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijantimicag.2011.01.025","volume":"38","author":"D Contou","year":"2011","unstructured":"Contou D, Fichet J, Grimaldi D, et al. Early life-threatening lactic acidosis following a single infusion of linezolid.[J]. Int J Antimicrob Agents. 2011;38(1):84\u20135.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1196_CR26","first-page":"50","volume":"16","author":"S Baldelli","year":"2022","unstructured":"Baldelli S, Alessia M, Giuseppe P, et al. Linezolid Intoxication with Extreme Lactate Blood Levels Successfully Treated with Dialytic Treatment in ICU: A Case Report.[J]. Recent Adv Inflamm Allergy Drug Discov. 2022;16(1):50\u20133.","journal-title":"Recent Adv Inflamm Allergy Drug Discov"},{"issue":"2","key":"1196_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijantimicag.2010.02.019","volume":"36","author":"K Matsumoto","year":"2010","unstructured":"Matsumoto K, Takeshita A, Ikawa K, et al. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.[J]. Int J Antimicrob Agents. 2010;36(2):179\u201381.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1196_CR28","doi-asserted-by":"publisher","first-page":"101701","DOI":"10.1016\/j.bjid.2021.101701","volume":"26","author":"CC Chen","year":"2022","unstructured":"Chen CC, Liu WT, Lin SH. Lactic acidosis associated with standard dose linezolid in a kidney recipient with impaired renal function.[J]. Braz J Infect Dis. 2022;26(1):101701.","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"1196_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/00365548.2011.608712","volume":"44","author":"Y Hiraki","year":"2012","unstructured":"Hiraki Y, Tsuji Y, Hiraike M, et al. Correlation between serum linezolid concentration and the development of thrombocytopenia.[J]. Scand J Infect Dis. 2012;44(1):60\u20134.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"1196_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10156-010-0080-6","volume":"17","author":"Y Tsuji","year":"2011","unstructured":"Tsuji Y, Hiraki Y, Matsumoto K, et al. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.[J]. J Infect Chemother. 2011;17(1):70\u20135.","journal-title":"J Infect Chemother"},{"issue":"0","key":"1196_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jfma.2020.06.011","volume":"120","author":"CN Cheng","year":"2021","unstructured":"Cheng CN, Wu CC, Kuo CH, et al. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions.[J]. J Formos Med Assoc. 2021;120(0):466\u201375.","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"1196_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2007.04.005","volume":"26","author":"KL Leach","year":"2007","unstructured":"Leach KL, Swaney SM, Colca JR, et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.[J]. Mol Cell. 2007;26(3):393\u2013402.","journal-title":"Mol Cell"},{"issue":"7","key":"1196_CR33","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14740338.2017.1335305","volume":"16","author":"A Santini","year":"2017","unstructured":"Santini A, Ronchi D, Garbellini M, et al. Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes.[J]. Expert Opin Drug Saf. 2017;16(7):833\u201343.","journal-title":"Expert Opin Drug Saf"},{"issue":"36","key":"1196_CR34","doi-asserted-by":"publisher","first-page":"e12114","DOI":"10.1097\/MD.0000000000012114","volume":"97","author":"Y Mao","year":"2018","unstructured":"Mao Y, Dai D, Jin H, et al. The risk factors of linezolid-induced lactic acidosis: A case report and review.[J]. Med (Baltim). 2018;97(36):e12114.","journal-title":"Med (Baltim)"},{"issue":"5","key":"1196_CR35","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1592\/phco.27.5.771","volume":"27","author":"J Carson","year":"2007","unstructured":"Carson J, Jorge C, Jong-Hee C, et al. Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism.[J]. Pharmacotherapy. 2007;27(5):771\u20134.","journal-title":"Pharmacotherapy"},{"issue":"9","key":"1196_CR36","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1086\/374558","volume":"36","author":"L Bernard","year":"2003","unstructured":"Bernard L, Stern R, Lew D, Hoffmeyer P. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis. 2003;36(9):1197.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1196_CR37","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1086\/430441","volume":"40","author":"L Palenzuela","year":"2005","unstructured":"Palenzuela L, Hahn NM, Nelson RP Jr, et al. Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?[J]. Clin Infect Dis. 2005;40(12):e113\u20136.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1196_CR38","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1086\/501356","volume":"42","author":"AS De Vriese","year":"2006","unstructured":"De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis.[J]. Clin Infect Dis. 2006;42(8):1111\u20137.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01196-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:10:54Z","timestamp":1790359854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01196-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01196-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study follows the principles of the Declaration of Helsinki of the World Medical Association. The study protocol was approved by the Medical Ethics Committee of the Chinese People\u2019s Liberation Army (PLA) General Hospital (Ethical approval number: S2020-206-01), and written informed consent was obtained from all participants or their legal agents. This study fully protected patient privacy and personal information, and participants or legal representatives also consented to their data being published in a journal article.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"134"}}